drugset / Trial / NCT00349388

Safety and Compliance of Taking Mesalamine Once a Day in Pediatric Patients

NCT00349388

RandomizedParallel-groupOpen-labelTreatment

Summary

To determine whether once a day administration of Mesalamine is at least as safe and efficacious and administration of multiple doses a day in preventing clinical relapse of ulcerative colitis in children and adolescence.

Timeline

Start
2006-07
Primary completion
2011-01
Completion
2011-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Mesalamine Small molecule

Indications